Gelibter, Stefano
Genchi, Angela
Callea, Marcella
Anzalone, Nicoletta
Galantucci, Sebastiano
Volonté, Maria Antonietta
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 22 June 2020
Revised: 7 September 2020
Accepted: 8 September 2020
First Online: 17 September 2020
Compliance with ethical standards
:
: S Gelibter, A Genchi, M Callea, S Galantucci, MA Volonté declare no disclosures. N Anzalone is speaker/consultant for Bayer Healthcare and Bracco diagnostic. M Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>; received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The patients provided their written informed consent for this report.
: The patient gave her informed consent for this report.